EQT Foundation Makes SAFE Investment in Syngular Technology

October 20, 2025

EQT Foundation has invested €100,000 via a SAFE in Hong Kong-based Syngular Technology to support scaling its AI- and AR-powered surgical guidance platform across Hong Kong and to build capacity for growing clinical demand. Syngular's system—used in 80+ real patient cases and piloted with the Hong Kong Hospital Authority—combines real-time AR overlays, AI anatomical segmentation and digital-twin generation to improve surgical precision and reduce operating time.

Buyers
EQT Foundation
Targets
Syngular Technology
Industry
Medical Devices
Location
Hong Kong
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.